Oncomatryx will attend BIO EUROPE SPRING 2018, the essential appointment in biotechnology BIO EUROPE SPRING 2018 March 12-14, 2018 Amsterdam, The Netherlands https://ebdgroup.knect365.com/bioeurope- If you are also attending this event and you would like
Antibody Drug Conjugates Against Tumor Stroma: The Beginning of The End? by Mirella Zulueta, Business Development Director at Oncomatryx The potential of a technology trigger Despite many research breakthroughs
Oncomatryx at the “Cancer Metabolism and the Tumour Microenvironment Conference”. 9-12, November. Paphos, Cyprus. Myriam Fabre, PhD. (Oncomatryx R&D Director) will attend the conference as speaker: TARGETING TUMOR MICROENVIRONMENT TO
BIO-EUROPE Spring 2016. April 4-6, 2016. Stockholm, Sweden. Oral Presentation: “Tumor microenvironment - targeted biopharmaceuticals”. Laureano Simón, PhD If you are also attending Bio-Europe and would like to meet us please fill this
Published by LA VANGUARDIA NEWSPAPER 2015-12-15. Oncomatryx amplía capital para completar la fase preclínica de medicamentos contra el estroma tumoral La empresa vasca Oncomatryx ha finalizado una ronda de
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.